Bionano Genomics Stock Technical Analysis
BNGO Stock | USD 0.79 0.03 3.95% |
As of the 23rd of April, Bionano Genomics shows the Standard Deviation of 3.84, risk adjusted performance of (0.09), and Mean Deviation of 2.96. Bionano Genomics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Bionano Genomics, which can be compared to its peers. Please confirm Bionano Genomics variance and potential upside to decide if Bionano Genomics is priced correctly, providing market reflects its regular price of 0.79 per share. As Bionano Genomics is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Bionano Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bionano, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BionanoBionano |
Bionano Genomics Analyst Consensus
Target Price | Advice | # of Analysts | |
13.2 | Strong Buy | 4 | Odds |
Most Bionano analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bionano stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bionano Genomics, talking to its executives and customers, or listening to Bionano conference calls.
Bionano Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Bionano Genomics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bionano Genomics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Bionano Genomics Trend Analysis
Use this graph to draw trend lines for Bionano Genomics. You can use it to identify possible trend reversals for Bionano Genomics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Bionano Genomics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Bionano Genomics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Bionano Genomics applied against its price change over selected period. The best fit line has a slop of 0.0063 , which may suggest that Bionano Genomics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.51, which is the sum of squared deviations for the predicted Bionano Genomics price change compared to its average price change.About Bionano Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bionano Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bionano Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bionano Genomics price pattern first instead of the macroeconomic environment surrounding Bionano Genomics. By analyzing Bionano Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bionano Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bionano Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Dividend Yield | 0.005606 | 0.004983 | Price To Sales Ratio | 1.79 | 1.7 |
Bionano Genomics April 23, 2024 Technical Indicators
Most technical analysis of Bionano help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bionano from various momentum indicators to cycle indicators. When you analyze Bionano charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.09) | |||
Market Risk Adjusted Performance | (0.19) | |||
Mean Deviation | 2.96 | |||
Coefficient Of Variation | (597.76) | |||
Standard Deviation | 3.84 | |||
Variance | 14.72 | |||
Information Ratio | (0.19) | |||
Jensen Alpha | (0.91) | |||
Total Risk Alpha | (1.15) | |||
Treynor Ratio | (0.20) | |||
Maximum Drawdown | 22.34 | |||
Value At Risk | (6.06) | |||
Potential Upside | 5.6 | |||
Skewness | 0.1806 | |||
Kurtosis | 0.8135 |
Bionano Genomics April 23, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bionano stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 40,617 | ||
Daily Balance Of Power | 0.75 | ||
Rate Of Daily Change | 1.04 | ||
Day Median Price | 0.79 | ||
Day Typical Price | 0.79 | ||
Price Action Indicator | 0.02 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.Note that the Bionano Genomics information on this page should be used as a complementary analysis to other Bionano Genomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Bionano Stock analysis
When running Bionano Genomics' price analysis, check to measure Bionano Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionano Genomics is operating at the current time. Most of Bionano Genomics' value examination focuses on studying past and present price action to predict the probability of Bionano Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionano Genomics' price. Additionally, you may evaluate how the addition of Bionano Genomics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Bionano Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.81) | Revenue Per Share 1.058 | Quarterly Revenue Growth 0.305 | Return On Assets (0.33) | Return On Equity (1.35) |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.